Popular Media (Affiliate)
Reject the Biden Administration’s Eleventh-Hour Patent Power Grab
IP Watchdog
View Original Source
On its way out the door, the Biden administration took a parting shot at America’s most innovative companies in a self-described bid to “expand equitable patient access to products that emerge from NIH-owned patents.”
On the last workday before the inauguration, officials at the National Institutes of Health (NIH) quietly published new patent licensing guidelines. Any company that wants to license patented discoveries from NIH labs must now guarantee the “affordability, availability, acceptability, and sustainability” of any future products they develop.